UNSPSC 51143406: Caffeine/ergotamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN105. This VA Drug Class (CN105) classifies this compound as belonging to the group ANTIMIGRAINE AGENTS.

UNSPSC 51143406 Caffeine/ergotamine is a Commodity code that, based on recent state and local solicitation activity, does not align with the pharmaceutical products actually being procured under this classification. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—represents emergency-response medical supplies rather than caffeine or ergotamine products. State and local governments appear to be using this code inconsistently or inappropriately for opioid-reversal agents and related harm-reduction equipment, suggesting either a classification error in the source system or a misalignment between the code's nominal scope and procurement practice on the ground.

Seminole County, Florida issued the only recent activity captured under this code: an IFB posted June 30, 2026, with responses due July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year contract with a one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building. The procurement requires electronic bid submission through the county's e-Procurement Portal, includes E-Verify and drug-free workplace certification, and is potentially funded through FEMA with attendant federal compliance obligations. Vendors must cover all shipping and delivery costs. The code shows minimal recent activity overall, and this single opportunity's actual scope diverges substantially from the code's stated pharmaceutical classification, warranting verification of the correct UNSPSC assignment before pursuing work in this category.